EcoDrugPlus

Adenosine Deaminase

Ensembl ID : ENSCPOG00000006159
Gene Symbol: ADA
4 Cross references
219 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSCPOG00000038399
Gene Symbol: ADRA1A
2 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSCPOG00000019316
Gene Symbol: ADRA1B
2 Cross references
265 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSCPOG00000039340
Gene Symbol: ADRA1D
2 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSCPOG00000013367
Gene Symbol: ADRA2B
2 Cross references
222 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSCPOG00000014955
Gene Symbol: ADRB1
4 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSCPOG00000012753
Gene Symbol: ADRB2
2 Cross references
265 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSCPOG00000000590
Gene Symbol: AGER
2 Cross references
170 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSCPOG00000032408
Gene Symbol: ADH5
2 Cross references
403 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSCPOG00000001285
Gene Symbol: AKR1B1
2 Cross references
426 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSCPOG00000006072
Gene Symbol: GAA
2 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSCPOG00000007933
Gene Symbol: AOC1
2 Cross references
233 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).